tradingkey.logo

Cabaletta Bio Inc <CABA.OQ> expected to post a loss of 64 cents a share - Earnings Preview

ReutersMay 9, 2025 2:44 PM
  • Cabaletta Bio Inc CABA.OQ CABA.O is expected to show no change in quarterly revenue when it reports results on May 13 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Cabaletta Bio Inc is for a loss of 64 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 1.4% in the last three months. ​

  • Wall Street's median 12-month price target for Cabaletta Bio Inc is $17.00​, above​ its last closing price of $1.21. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.63

-0.65

Missed

-3

Sep. 30 2024

-0.59

-0.60

-0.62

Missed

-4

Jun. 30 2024

-0.56

-0.55

-0.56

Missed

-2.2​

Mar. 31 2024

-0.47

-0.48

-0.51

Missed

-7.2

​​Dec. 31 2023

-0.40

-0.39

-0.46

Missed

-17.2

Sep. 30 2023

-0.41

-0.40

-0.37

Beat

8.3​

Jun. 30 2023

-0.44

-0.44

-0.37

Beat

16.4

Mar. 31 2023

-0.48

-0.48

-0.45

Beat

6.3

This summary was machine generated May 9 at 14:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI